Pharmaceuticals and Endocrine-Disrupting Compounds in Drinking Water

Biophysico-Chemical Processes of Anthropogenic Organic Compounds in Environmental Systems

Volumn , Issue , 2011, Pages 233-249

  Gerrity, Daniel W ^a   Benotti, Mark J ^a   Reckhow, David A ^b   Snyder, Shane A ^a  

^a SOUTHERN NEVADA WATER AUTHORITY   (United States)

^b University of Massachusetts   (United States)

Author keywords

Pharmaceutical and EDC removal during drinking water treatment; Pharmaceuticals and endocrine disrupting compounds (EDCs) occurrence in drinking water; Pharmaceuticals and endocrine disrupting compounds in drinking water

Indexed keywords

EID: 84886356658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470944479.ch9     Document Type: Chapter

References (60)

1. Barnes, K. K., Kolpin, D. W., Furlong, E. T., Zaugg, S. D., Meyer, M. T., and Barber, L. B. (2008), A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States. I. Groundwater, Sci. Total Environ. 402(2-3), 192-200.
2. Bellona, C., Drewes, J. E., Oelker, G., Luna, J., Filteau, G., and Amy, G. (2008), Comparing nanofiltration and reverse osmosis for drinking water augmentation. J. Am. Water Works Assoc. 100(9), 102-116.
3. Beltran, F. J. (2004), Ozone Reaction Kinetics for Water and Wastewater Systems, Lewis Publishers, CRC Press, Boca Raton, FL.
4. Benotti, M. J. and Brownawell, B. J. (2007), Distributions of pharmaceuticals in an urban estuary during both dry-and wet-weather conditions, Environ. Sci. Technol. 41(16), 57955802.
5. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holaday, J. C., Stanford, B. D., and Snyder, S. A. (2009a), Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water, Environ. Sci. Technol. 43(3), 597-603.
6. Benotti, M. J., Stanford, B. D., Wert, E. C., and Snyder, S. A. (2009b), Evaluation of a photocatalytic reactor membrane pilot system for the removal of pharmaceuticals and endocrine disrupting compounds from water, Water Res. 43, 1513-1522.
7. Bruchet, A., Hochereau, C., Picard, C., Decottignies, V., Rodrigues, J. M., and Janex-Habibi, M. L. (2005), Analysis of drugs and personal care products in French source and drinking waters: The analytical challenge and examples of application, Water Sci. Technol. 52(8), 53-61.
8. Canosa, P., Morales, S., Rodriguez, I., Rubi, E., Cela, R., and Gomez, M. (2005), Aquatic degradation of triclosan and formation of toxic chlorophenols in presence of low concentrations of free chlorine. Anal. Bioanal. Chem. 383(7-8), 1119-1126.
9. Clara, M., Kreuzinger, N., Strenn, B., Gans, O., and Kroiss, H. (2005), The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res. 39(1), 97-106.
10. Cleasby, J. L. and Logsdon, G. S. (1999), Granular bed and precoat filtration, in Water Quality and Treatment: A Handbook of Community Water Supplies, Letterman. R. D., ed., McGraw-Hill, New York.
11. Crittenden, J. C., Trussell, R. R., Hand, D. W., Howe, K. J., and Tchobanoglous, G. (2005), Water Treatment: Principles and Design, 2nd ed., Wiley, Hoboken, NJ.
12. Daughton, C. G. and Ternes, T. A. (1999), Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 107, 907-938.
13. Deborde, M. and von Gunten, U. (2008), Reactions of chlorine with inorganic and organic compounds during water treatment- kinetics and mechanisms: A critical review, Water Res. 42(1-2), 13-51.
14. Donn, J., Mendoza, M., and Pritchard, J. (2008), Pharmaceuticals Found in Drinking Water, Affecting Wildlife and Maybe Humans, The Associated Press.
15. Garrison, A. W., Pope, J. D., and Allen, F. R. (1976), GC/MS analysis of organic compounds in domestic wastewaters, in Identification and Analysis of Organic Pollutants in Water, Keith, C. H., ed., Ann Arbor Science Publishers, Ann Arbor, MI, pp. 516-556.
16. Gerrity, D., Stanford, B. D., Trenholm, R. A., and Snyder, S. A. (2009), An evaluation of a pilot-scale nonthermal plasma advanced oxidation process for trace organic compound degradation, Water Res. 44, 493-504.
17. Glassmeyer, S. T., Furlong, E. T., Kolpin, D.W., Cahill, J. D., Zaugg, S. D., Werner, S. L., Meyer, M. T., and Kryak, D. D. (2005), Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination, Environ. Sci. Technol. 39(14), 5157-5169.
18. Gregory, R. and Zebel, T. F. (1999), Sedimentation and flotation, in Water Quality and Treatment: A Handbook of Community Water Supplies, Letterman, R. D., ed., McGraw-Hill, New York.
19. Heberer, T. and Stan, H. J. (1997), Determination of clofibric acid and N-(phenylsulfonyl)-sarcosine in sewage, river and drinking water, Int. J. Environ. Anal. Chem. 67(1-4), 113-123.
20. Heberer, T. (2002), Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data, Toxicol. Lett. 131(1-2), 5-17.
21. Hignite, C. and Azarnoff, D. L. (1977), Drugs and drug metabolites as environmental contaminants-chlorophenoxyisobutyrate and salicylic acid in sewage water effluent, Life Sci. 20(2), 337-341.
22. Hua, G. and Reckhow, D. A. (2008), DBP formation during chlo-rination and chloramination: Effect of reaction time, pH, dosage, and temperature, J. Am. Water Works Assoc. 100(8), 82-95.
23. Huber, M. M., Canonica, S., Park, G. Y., and Von Gunten, U. (2003), Oxidation of pharmaceuticals during ozonation and advanced oxidation processes, Environ. Sci. Technol. 37(5), 1016-1024.
24. Joss, A., Keller, E., Alder, A. C., Gobel, A., McArdell, C. S., Ternes, T., and Siegrist, H. (2005), Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res. 39, 3137-3152.
25. Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., and Snyder, S. A. (2007), Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res. 41(5), 1013-1021.
26. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T. (2002), Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance, Environ. Sci. Technol. 36(6), 1202-1211.
27. Kuehn, B. M. (2008), Traces of drugs found in drinking water: Health effects unknown, safer disposal urged, J. Am. Med. Assoc. 299(17), 2011-2013.
28. Langlais, R. T., Reckhow, D. A., and Brink, D. R. (1991), Ozone in Water Treatment: Application and Engineering. Lewis Publishers, Chelsea, MI.
29. Lei, H. X. and Snyder, S. A. (2007), 3D QSPR models for the removal of trace organic contaminants by ozone and free chlorine, Water Res. 41(18), 4051-4060.
30. Letterman, R. D. and Amirtharajah, A. (1999), Coagulation and flocculation, in Water Quality and Treatment: A Handbook of Community Water Supplies, Letterman, R. D., ed., McGraw-Hill, New York.
31. Radjenovic, J., Petrovic, M., and Barcelo, D. (2009), Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 43, 831841.
32. Razavi, B., Song, W. H., Cooper, W. J., Greaves, J., and Jeong, J. (2009), Free-radical-induced oxidative and reductive degradation of fibrate pharmaceuticals: Kinetic studies and degradation mechanisms, J. Phys. Chem. A 113(7), 1287-1294.
33. Reckhow, D. A., Singer, P. C., and Malcolm, R. L. (1990), Chlo-rination of humic materials-by-product formation and chemical interpretations, Environ. Sci. Technol. 24(11), 1655-1664.
34. Rosario-Ortiz, F. L., Mezyk, S. P., Wert, E. C., Doud, D. F. R., Singh, M. K., Xin, M., Baik, S., and Snyder, S. A. (2008), Effect of ozone oxidation on the molecular and kinetic properties of effluent organic matter, J. Adv. Oxid. Technol. 11(3), 529-535.
35. Rosenfeldt, E. J. and Linden, K. G. (2004), Degradation of endocrine disrupting chemicals bisphenol A, ethynyl estradiol, and estradiol during UV photolysis and advanced oxidation processes, Environ. Sci. Technol. 38(20), 5476-5483.
36. Routt, J. C., Mackey, E., Whitby, E., Connell, G., Passantine, L., and Noak, R. (2007), Tracking Utility Disinfection over Four Decades of Change: Disinfection Survey 2007-Preliminary Summary, American Water Works Association (AWWA), Charlotte, NC.
37. Santoke, H., Song, W. H., Cooper, W. J., Greaves, J., and Miller, G. E. (2009), Free-radical-induced oxidative and reductive degradation of fluoroquinolone pharmaceuticals: Kinetic studies and degradation mechanisms, J. Phys. Chem. A 113(27), 78467851.
38. Singer, P. C. and Reckhow, D. A. (1999), Chemical Oxidation, in Water Quality and Treatment: A Handbook of Community Water Supplies, Letterman, R. D., ed., McGraw-Hill, New York.
39. Snyder, S. A., Keith, T. L., Verbrugge, D. A., Snyder, E. M., Gross, T. S., Kannan, K., and Giesy, J. P. (1999), Analytical methods for detection of selected estrogenic compounds in aqueous mixtures, Environ. Sci. Technol. 33(16), 2814-2820.
40. Snyder, S. A., Villeneuve, D. L., Snyder, E. M., and Giesy, J. P. (2001), Identification and quantification of estrogen receptor agonists in wastewater effluents, Environ. Sci. Technol. 35(18), 3620-3625.
41. Snyder, S. A., Westerhoff, P., Yoon, Y., and Sedlak, D. L. (2003), Pharmaceuticals, personal care products, and endocrine disrup-tors in water: Implications for the water industry, Environ. Eng. Sci. 20(5), 449-469.
42. Snyder, S. A., Wert, E. C., Rexing, D. J., Zegers, R. E., and Drury, D. D. (2006), Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater, Ozone Sci. Eng. 28(6), 445-460.
43. Snyder, S. A., Wert, E. C., Lei, H. X., Westerhoff, P., and Yoon, Y. (2007), Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes, AWWA Research Foundation, Denver.
44. Snyder, S. A., Trenholm, R. A., Snyder, E. M., Bruce, G. M., Pleus, R. C., and Hemming, J. D. C. (2008a), Toxicological Relevance of EDCs and Pharmaceuticals in Drinking Water, AWWA Research Foundation, Denver.
45. Snyder, S. A., Vanderford, B. J., Drewes, J. E., Dickenson, E., Snyder, E. M., Bruce, G. M., and Pleus, R. C. (2008b), State of Knowledge of Endocrine Disruptors and Pharmaceuticals in Drinking Water, AWWA Research Foundation, Denver.
46. Song, W. H., Chen, W. S., Cooper, W. J., Greaves, J., and Miller, G. E. (2008), Free-radical destruction of beta-lactam antibiotics in aqueous solution, J. Phys. Chem. A 112(32), 7411-7417.
47. Song, W. H., Cooper, W. J., Peake, B. M., Mezyk, S. P., Nickelsen, M. G., and O'Shea, K. E. (2009), Free-radical-induced oxidative and reductive degradation of N,N'-diethyl-m-toluamide (DEET): Kinetic studies and degradation pathway, Water Res. 43(3), 635-642.
48. Stackelberg, P. E., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Henderson, A. K., and Reissman, D. B. (2004), Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant, Sci. Total Environ. 329(1-3), 99-113.
49. Standley, L. J., Kaplan, L. A., and Smith, D. (2000), Molecular tracers of organic matter sources to surface water resources, Environ. Sci. Technol. 34(15), 3124-3130.
50. Stumm-Zollinger, E. and Fair, G. M. (1965), Biodegradation of steroid hormones, J. Water Pollut. Control. Fed. 37, 1506-1510.
51. Tabak, H. H. and Bunch, R. L. (1970), Steroid hormones as water pollutants. I. Metabolism of natural and synthetic ovulation-inhibiting hormones by microorganisms of activated sludge and primary settled sewage, Dev. Ind. Microbiol. 11, 367-376.
52. Tchobanoglous, G., Burton, F. L., and Stensel, H. D. (2004), Wastewater Engineering: Treatment and Reuse, 4th ed., McGraw-Hill, New York.
53. Ternes, T. A. (1998), Occurrence of drugs in German sewage treatment plants and rivers, Water Res. 32(11), 3245-3260.
54. Ternes, T. A., Stumpf, M., Mueller, J., Haberer, K., Wilken, R. D., and Servos, M. (1999), Behavior and occurrence of estrogens in municipal sewage treatment plants. I. Investigations in Germany, Canada and Brazil, Sci. Total Environ. 225(1-2), 81-90.
55. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H. J., Gulde, B. H., Preuss, G., Wilme, U., and Seibert, N. Z. (2002), Removal of pharmaceuticals during drinking water treatment, Environ. Sci. Technol. 36(17), 3855-3863.
56. Vanderford, B. J., Mawhinney, D. B., Rosario-Ortiz F. L., and Snyder, S. A. (2008), Real-time detection and identification of aqueous chlorine transformation products using QTOF MS, Anal. Chem. 80(11), 4193-4199.
57. Wert, E. C., Rosario-Ortiz, F. L., Drury, D. D., and Snyder, S. A. (2007), Formation of oxidation byproducts from ozonation of wastewater, Water Res. 41(7), 1481-1490.
58. Wert, E. C., Rosario-Ortiz, F. L., and Snyder, S. A. (2009), Effect of ozone exposure on the oxidation of trace organic contaminants in wastewater, Water Res. 43(4), 1005-1014.
59. Westerhoff, P., Mezyk, S. P., Cooper, W. J., andMinakata, D. (2007), Electron pulse radiolysis determination of hydroxyl radical rate constants with Suwannee river fulvic acid and other dissolved organic matter isolates, Environ. Sci. Technol. 41(13), 4640-4646.
60. Ye, Z. Q., Weinberg, H. S., and Meyer, M. T. (2007), Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry, Anal. Chem. 79(3), 1135-1144.